MedTrace Logo

Clinical Trial to Evaluate the Effect of an Oral Probiotic on the Vaginal Flora

NCT03923985 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-02-11

No results posted yet for this study

Summary

Clinical trial to evaluate the effect of a probiotic containing Lactobacillus Crispatus on the vaginal flora

Conditions

  • Vaginal Flora

Interventions

DIETARY_SUPPLEMENT

Probiotic containing Lactobacillus Crispatus

1 tablet / day of probiotic (275 mg of live probiotic lactic ferments: 10 Mld L. fermentum (SGL 10), 10 Mld L. gasseri, 10 Mld L. casei, 10 Mld L. acidophilus, 10 Mld L. crispatus) during 2 months.

Sponsors & Collaborators

  • Instituto Palacios

    lead OTHER

Principal Investigators

  • Santiago Palacios, PhD · Instituto Palacios

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-21
Primary Completion
2019-09-30
Completion
2019-10-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03923985 on ClinicalTrials.gov